Qinghai Spring(SH:600381) Shang Hai Zheng Quan Bao·2025-06-16 19:05Group 1 - The board of directors of Qinghai Spring Pharmaceutical Resources Technology Co., Ltd. held its 13th meeting of the 9th session on June 16, 2025, with all 7 directors present, and the meeting was deemed legally valid [2][4] - The board approved the proposal regarding the recognition of daily related transactions and the estimated daily related transactions for 2025, which was submitted after review by independent directors [3][30] - The proposal received 6 votes in favor, with no votes against or abstentions, and will be submitted to the shareholders' meeting for further approval [4][5] Group 2 - The company will hold its first temporary shareholders' meeting on July 3, 2025, to review the proposal regarding the recognition of daily related transactions [5][10] - The voting method for the shareholders' meeting will combine on-site voting and online voting through the Shanghai Stock Exchange network voting system [10][11] - The company has ensured that the daily related transactions are necessary for its normal production and operation, adhering to principles of fairness and transparency, and will not harm the interests of the company or minority investors [28][36] Group 3 - The actual amount of transactions with Yibin Tinghua Wine Industry Development Co., Ltd. in 2024 was 79 million yuan (including tax) [31] - The company has established a pricing policy for related transactions based on market prices and reasonable profit margins, ensuring that the transactions are conducted fairly [35][36] - The independent directors concluded that the related transactions are necessary for the company's operations and will not affect its independence or the interests of non-related shareholders [38][39]